World AMR Awareness Week is observed from 18 to 24 November. The World Health Organization campaign pages we opened on 16 November 2026 give the 2026 theme as "One Health, one action: Prevent AMR now". It is a global awareness campaign on antimicrobial resistance (AMR). It is not, in the sources we opened, a new Indian rule for private clinics.
If you run a small clinic, a nursing home OPD or a one-doctor chamber, the useful work this week is on the record you already write: why an antibiotic was started, how long the course runs, and whether the slip is complete enough for a Schedule H or Schedule H1 sale. This page turns that into a 5-point record check. It does not tell you which antibiotic to choose, and it does not give doses.
The September 2026 CDSCO circular on painkillers and antibiotics, and the five points it addresses to prescribers, are covered in our CDSCO circular guide. This page does not repeat that circular. It sits beside it, for the awareness week, and adds the official Indian documents that circular does not discuss: the current national treatment guidelines and the current national action plan.
Information as of 16 November 2026, Asia/Calcutta. This is a general guide, not medical or legal advice. The 5-point check is our reading of the sources listed below. It is not an official World Health Organization, Ministry of Health and Family Welfare, CDSCO, NCDC or ICMR checklist. Recheck the current official notice before you change clinic policy.
The short answer
- A week, not a new gazette. World AMR Awareness Week runs from 18 to 24 November each year. The 2026 theme, on the World Health Organization campaign and event pages we opened, is "One Health, one action: Prevent AMR now". The event page title capitalises the same theme as "One Health, One Action: Prevent AMR Now". We use the wording in the campaign text.
- India already has rules and guidance. Antibiotics are included in Schedule H and Schedule H1 of the Drugs Rules, 1945, and are sold only under the prescription of a Registered Medical Practitioner, as a 28 March 2025 Press Information Bureau reply states. CDSCO's 21 September 2026 circular restates those rules and asks prescribers to use antibiotics only when clinically indicated, and to avoid an unnecessarily prolonged duration. The National Treatment Guidelines, Version 2.0, November 2025, guide empiric use. NAP-AMR 2.0 (2025-2029) is the current national plan, launched on 18 November 2025.
- The H1 register is the chemist's record. Most antibiotic drugs are included in Schedule H1, according to the September circular. The separate H1 register, kept for three years, is filled in at the time of retail supply. It is not a new clinic register.
- What we did not find. We did not find, in the sources for this page, a mandate, start date or new form that a private clinic must adopt only because World AMR Awareness Week has begun.
- What Medabha does. It can store the visit note, including the diagnosis or indication you type, print a duration in its own column, and print the medicine line you wrote. It does not judge whether an antibiotic is indicated, it does not keep an H1 register, and it does not flag a medicine as Schedule H or H1.
What World AMR Awareness Week 2026 is
The World Health Organization describes World AMR Awareness Week (WAAW) as a global campaign to raise awareness and increase understanding of antimicrobial resistance, and to promote global action to tackle the emergence and spread of drug-resistant infections. It is observed annually from 18 to 24 November.
AMR, in that official wording, occurs when bacteria, viruses, fungi and parasites no longer respond to medicines intended to kill them. As drug resistance increases, antimicrobial agents, such as antibiotics, antifungals, antivirals and antiparasitics, become ineffective, and infections become increasingly difficult or impossible to treat. The campaign pages stress that the health of people, animals, plants and the environment is connected, which is the "One Health" part of the theme. This page is written for a human-health clinic record. It does not cover veterinary or agricultural use.
The campaign calls on everyone to do their part, and names health professionals among those already taking action. The pages we opened do not set an Indian legal deadline, a new prescription form, or a reporting duty for a private OPD. A Press Information Bureau reply dated 28 March 2025, given in the Lok Sabha, says the National Programme on AMR Containment conducts awareness activities for health care workers and the community during this week every year. That reply still uses the older phrase "World Antibiotic Awareness Week" for the same annual week. We use the current World Health Organization name, World AMR Awareness Week, and we treat that PIB line as confirmation that India already marks the week, not as a new 2026 instruction.
Our reading, only: if you do one practical thing this week, make the antibiotic record you already write easier to defend later, for the patient, for the chemist, and for yourself.
What official Indian guidance already says
The week does not arrive in a vacuum. These are the official Indian sources we opened, and the limits of what we take from each.
CDSCO's 21 September 2026 circular, listed on the CDSCO Circulars page with a release date of 22 September 2026, is titled "Indiscriminate use of painkillers (NSAIDs), antibiotics and associated risk of Chronic Kidney Disease". Our separate guide quotes Section B in full and turns it into an OPD checklist. For this page, four lines matter. Antibiotics should be prescribed only when clinically indicated (B.I). They should be prescribed judiciously and in accordance with applicable antimicrobial stewardship principles, taking into account the likely organism, the site and severity of infection and, where appropriate, investigations and local susceptibility patterns (B.IV). Unnecessary combination therapy, inappropriate selection, incorrect dosing and an unnecessarily prolonged duration should be avoided (B.V). Patients should take antibiotics strictly as advised, and should not share them or use leftovers (Section A.III). This page does not repeat the NSAID points, and it adds no dose.
The same circular says most antibiotic drugs are included in Schedule H1, and that Schedule H and H1 drugs must not be sold at retail except in accordance with the Drugs Rules, 1945. A 28 March 2025 Press Information Bureau reply says the same in shorter form: antibiotics are included in Schedule H and H1, they have specific caution labelling, and they are sold only under the prescription of a Registered Medical Practitioner.
The Red Line campaign is described in that same PIB reply: the Ministry of Health and Family Welfare launched a Red Line awareness campaign on antimicrobial resistance, urging people not to use medicines marked with a red vertical line, including antibiotics, without a doctor's prescription. That is a public-awareness campaign. We have not, in the sources for this page, treated the red line on a pack as a substitute for the Schedule H1 caution the Drugs Rules and the September circular describe, and we have not seen a line that says every antibiotic pack in India carries a red line. Our reading: you can still use it as a one-line reminder to the patient, when the pack in front of you has that mark.
The National Treatment Guidelines for Antimicrobial Use in Infectious Disease Syndromes, Version 2.0, November 2025, were developed jointly by the National Centre for Disease Control (NCDC), Directorate General of Health Services, and the Indian Council of Medical Research (ICMR). We opened the official PDF from ncdc.mohfw.gov.in on 16 November 2026. The introduction says the guidelines are intended to guide the empiric use of antimicrobials where the severity of the infection means treatment may have to start before culture and susceptibility results are available. The instructions for use say they are general guidelines, and that they primarily cater to places which do not have their own local hospital or institute antibiotic policy. They encourage institutions to formulate such a policy, and say these guidelines can serve as a broad framework. They also say, in a line repeated at the front of the document, that before initiating the empiric therapy given in the guidelines, appropriate clinical samples must be sent to the laboratory so that, once results are available, pathogen-based targeted therapy can be started. They say empiric prescriptions must be modified based on culture and antimicrobial susceptibility testing. This page does not copy any regimen, drug name or dose from those chapters.
NAP-AMR 2.0 (2025-2029), Version 2.0, November 2025, is the current National Action Plan on Antimicrobial Resistance. We opened the official PDF from ncdc.mohfw.gov.in. A Press Information Bureau release dated 18 November 2025 says Union Health Minister Jagat Prakash Nadda launched it that day. The plan is a "One Health" and whole-of-government document. The fourth strategic objective is to optimize the use of antimicrobial agents in humans, animals and food, through uninterrupted access and judicious use. The document says national treatment guidelines for antimicrobial use have been released from time to time by NCDC and ICMR "to guide healthcare facilities to formulate their own facility level antibiotic guidelines and policies relevant for the local context and to train physicians on judicious use of antibiotics." It also records that CDSCO has conducted awareness and enforcement drives for Schedule H and H1 of the Drugs Rules, which prohibit sales of antimicrobials without a medical prescription, and it lists continued enforcement of Schedule H and H1, through circulars to State licensing authorities, as an activity CDSCO will keep monitoring. Towards implementation, each stakeholder ministry is expected to develop a roadmap "ensuring engagement of private sector", among other partners. We did not find a page of this plan that creates a new, dated duty for every private solo clinic. Our reading: it is national policy, not a clinic form.
A URL given in the 28 March 2025 PIB reply for infection-prevention guidelines, https://ncdc.mohfw.gov.in/antimicrobial-resistance-amr-containment/, returned "not found" when we opened it on 16 November 2026. We therefore do not quote that page.
What these sources do not say
The table below is a reading aid, not an official notice. Every "stated in these sources" line is taken from the documents named above. Every "not found" line means we did not find it in those sources on 16 November 2026.
| Topic | Stated in these sources | Not found in these sources |
|---|---|---|
| World AMR Awareness Week | An annual global awareness campaign, 18 to 24 November; 2026 theme "One Health, one action: Prevent AMR now"; India already marks the week with awareness activities | A new legal duty, form or start date for private clinics that applies only because the week has begun |
| Schedule H and H1 | Antibiotics are included in these schedules and are sold only on a Registered Medical Practitioner's prescription; most antibiotic drugs are in H1, according to the September circular; the H1 supply register is kept by the retailer for three years | A requirement that the clinic itself keep an H1 register; a new 2026 change to that register because of the awareness week |
| Indication and duration | The September circular: prescribe only when clinically indicated, and avoid an unnecessarily prolonged duration; the treatment guidelines: make a clinical diagnosis, and send appropriate samples before starting the empiric therapy they list | A Drugs Rules field that, in the text we use, requires the indication to be printed on the slip itself |
| National treatment guidelines | Version 2.0, November 2025, for empiric use, as a framework for a local policy, with samples before empiric therapy and review when results return | A statement that a private solo clinic must adopt the document as its only protocol, or a licence condition we can quote |
| NAP-AMR 2.0 | A 2025-2029 national plan, launched 18 November 2025, including judicious use, Schedule H and H1 enforcement, and later private-sector engagement in ministry roadmaps | A dated mandate that every private OPD must file a new AMR report this week |
If a later official notice fills any of those gaps, that notice is the one to follow.
A 5-point antibiotic record check (our reading)
This list is our reading for a small clinic or a nursing-home OPD, written for record-keeping. It is not an official World Health Organization, CDSCO, NCDC or ICMR checklist, and it is not a clinical protocol. It adds no dosing advice.
1. Write why the antibiotic is being started, on the visit record.
The September circular says antibiotics should be prescribed only when clinically indicated, after considering the patient's condition, age, co-morbidities, other medicines and relevant risk factors, and that stewardship includes the likely organism, the site and the severity. The National Treatment Guidelines open their "basics of antibiotic prescriptions" with making a clinical diagnosis from the history and the findings, and they describe empiric prescribing as something that happens after a clinical diagnosis. Rule 65(10) of the Drugs Rules, 1945, which we discuss in the next point, lists the patient's name and address, the dose and the total amount on the prescription. It does not, in the text we use, list the indication as a required field on the slip itself.
Our reading: write the indication, or the working diagnosis, in the consult note you keep, even if it does not appear as a separate line on the printed slip. A later query, a second visit, or a review of the course is much harder to reconstruct from a medicine name alone. This is a documentation habit, not a new legal field we have invented.
2. Write a dose, a frequency and a fixed duration on the antibiotic line.
The September circular's opening says these drugs should be used only when clinically indicated, in the appropriate dose and for the appropriate duration, under a Registered Medical Practitioner. Section B.V asks prescribers to avoid an unnecessarily prolonged duration. Our circular guide already puts this as "a dose and a fixed number of days, not an open-ended 'till review'".
This page does not tell you how many days is right. That is a clinical decision, and the national treatment guidelines are the official reference for empiric choices. What the record should show is a duration you actually chose, written clearly enough for the patient and the chemist.
3. Make the prescription complete enough for a Schedule H or H1 sale.
Rule 65(10) already says, for the sale condition in Rule 65(9), that a prescription shall be in writing, signed with the prescriber's usual signature and dated, shall specify the patient's name and address, and shall indicate the total amount of the medicine to be supplied and the dose to be taken. The doctor's name, qualification and registration number come from the ethics regulations, not from the awareness week. Those letterhead particulars are explained in our qualifications guide. Layout and printing are covered in our digital prescription and prescription printing guides.
The H1 layer on top of that, for medicines in Schedule H1, includes the retailer's separate register, kept for three years, and the H1 caution on the pack. That register is filled in at the time of supply, with the prescriber's name and address, the patient's name, the drug and the quantity. Our Pregabalin and Schedule H1 guide walks through the same rules for a recent H1 change. The awareness week does not, in the sources we opened, add a new clinic-side register.
4. Use the pack caution, and a short advice line, so leftovers and sharing are harder.
Section A.III of the September circular says antibiotics prescribed by a healthcare professional should be taken strictly as advised, and should not be shared or used from leftover medicines. The Red Line campaign, as described by PIB, urges people not to use medicines marked with a red vertical line, including antibiotics, without a doctor's prescription.
Our reading: one plain sentence at the end of the consult, and on the advice line if you use one, is enough for this point. Take only what was written, for the days that were written. Do not share the course, and do not keep it for next time. If the pack in the patient's hand has a red line, you can point to it. This is advice and labelling awareness, not a new statutory register in the clinic.
5. Use official guidance as a reference, and record whether an investigation was sent.
The National Treatment Guidelines, Version 2.0, say that before initiating the empiric therapy they list, appropriate clinical samples must be sent so that treatment can be revised once results are available. They also say the document is a general framework, and that a local policy and a local antibiogram may modify the recommendations. NAP-AMR 2.0 treats those guidelines as part of the work of optimising use, and asks healthcare facilities to form their own facility-level policies for the local context.
Our reading, for a small clinic: you do not have to invent a hospital-style antimicrobial stewardship committee this week in order to mark the campaign. You can keep a copy of the current national guidelines to hand, write whether you sent a relevant sample, and write what you will do when the result returns. Do not paste a chapter from the guidelines onto your slip. Do not treat this page as a substitute for those chapters. If your institution already has its own policy, follow that policy.
What Medabha records, and what it does not
For the product as Medabha builds it today, see prescription software.
On the visit, you can write the consult note, including the diagnosis or indication, order or record investigations, and attach reports to the visit. Those notes and files stay on the patient record. Medabha does not judge whether an antibiotic was indicated, and it does not judge whether an investigation should have been sent.
On the prescription line, the form has separate fields for the medicine, the route, the dose, the frequency, the duration and the instructions. The duration is printed in its own column. Under Settings, you can save your own duration suggestions. Until you save your own list, the starter suggestions are "3 days", "5 days", "7 days", "10 days", "14 days", "1 month", "Till review" and "Continue till next visit". They appear as autocomplete on every prescription line, not only on antibiotics. You can type a fixed number of days instead. Signing is not blocked only because the duration is blank, or because a line still says "Till review".
Medabha flags a short list of drug-pair and condition clashes while you write the prescription and again when you sign. For antibiotics, that list includes clarithromycin or erythromycin with atorvastatin or simvastatin, trimethoprim or co-trimoxazole with methotrexate, and nitrofurantoin when severe kidney disease or G6PD deficiency is written on the chart. Some antibiotics also have pregnancy-related warnings when pregnancy is recorded, including doxycycline and nitrofurantoin near term. The code itself says this is not a complete interaction database. It warns; the prescriber decides. If a warning is showing, signing stops until you tick that you have reviewed it. You can still sign. There is no stewardship check that asks whether the antibiotic should have been started, whether two antibiotics overlap, or whether the course is too long.
The printed prescription can include your name, qualification and registration number, the visit date, the patient's name, and the medicine line you typed, including dose, frequency and duration. It does not flag a medicine as Schedule H or Schedule H1, and it does not keep an H1 register. As set out in our Schedule H1 guide, and still the case on the product as we checked it for this page, the printed slip does not include the patient's address, and it does not print a total quantity as a separate required field. If you need the patient's address and the total quantity on the slip, add them yourself until the product does.
Medabha is built for one doctor per clinic, with an optional receptionist. It is not a hospital antimicrobial stewardship system.
A screenshot to add when you have a real capture from a test clinic (do not invent one): a prescription line with the Duration field visible, showing a fixed number of days rather than a blank, and the duration column on the printed slip. Suggested path: /images/blog/antibiotic-duration-on-prescription.webp. Suggested alt text: "A Medabha prescription line with the Duration field filled in, and the duration printed in its own column on the slip."
Sources
- World Health Organization, "World AMR Awareness Week 2026," campaign page, theme "One Health, one action: Prevent AMR now", dates 18 to 24 November 2026, opened 16 November 2026, campaign page.
- World Health Organization, "World AMR Awareness Week 2026: One Health, One Action: Prevent AMR Now," event page, dates 18 to 24 November 2026, opened 16 November 2026, event page. The event page title capitalises the theme; the body of both pages uses "One Health, one action: Prevent AMR now".
- Press Information Bureau, Ministry of Health and Family Welfare, "Steps taken by the Government to increase surveillance and awareness of Antimicrobial Resistance (AMR)," 28 March 2025, 5:04 PM, PIB Delhi, PRID 2116222. Used for the Red Line campaign, Schedule H and H1, national treatment guidelines, and annual awareness activities during the week.
- Press Information Bureau, "Union Minister of Health and Family Welfare, Shri Jagat Prakash Nadda, launched the second version of the National Action Plan on Antimicrobial Resistance (2025-29)," 18 November 2025, 2:18 PM, PIB Delhi, PRID 2191165.
- National Centre for Disease Control and Ministry of Health and Family Welfare, "National Action Plan on Antimicrobial Resistance (NAP-AMR) (2025-2029), One Health Approach," Version 2.0, November 2025, PDF opened from ncdc.mohfw.gov.in on 16 November 2026.
- National Centre for Disease Control and Indian Council of Medical Research, "National Treatment Guidelines for Antimicrobial Use in Infectious Disease Syndromes," Version 2.0, November 2025, PDF opened from ncdc.mohfw.gov.in on 16 November 2026.
- Central Drugs Standard Control Organization, circular "Indiscriminate use of painkillers (NSAIDs), antibiotics and associated risk of Chronic Kidney Disease," 21 September 2026, listed on the CDSCO Circulars page with a release date of 22 September 2026. Quoted and discussed in our CDSCO circular guide.
What we could not confirm
- A new legal duty, form or deadline for private clinics that applies only because World AMR Awareness Week 2026 has begun.
- An official Indian 2026 campaign page, from the Ministry of Health and Family Welfare or NCDC, that we could open this week with a clinic-level checklist of its own. The 28 March 2025 PIB reply confirms that awareness activities are conducted during the week each year. We have not seen a separate 2026 operational order for clinics.
- A Drugs Rules requirement, in the text we use, that the indication must be printed on the prescription slip itself.
- A requirement that a private clinic keep its own Schedule H1 supply register.
- The infection-prevention page linked from the 28 March 2025 PIB reply, because that URL returned "not found" on 16 November 2026.
- Whether every antibiotic pack sold in India carries a red vertical line. The Red Line campaign, as PIB describes it, is an awareness campaign about medicines that are marked that way.
This is a general guide, not medical or legal advice. Information as of 16 November 2026, Asia/Calcutta. If a later official notice differs from the documents cited here, follow the notice.
Frequently asked questions
Does World AMR Awareness Week create a new legal duty for private clinics?
Not in the sources we opened. The World Health Organization campaign pages we opened on 16 November 2026 describe World AMR Awareness Week as a global awareness campaign, observed each year from 18 to 24 November. The 2026 theme is "One Health, one action: Prevent AMR now". A Press Information Bureau reply dated 28 March 2025 says the National Programme on AMR Containment conducts awareness activities for health care workers and the community during this week every year. We did not find, in those pages, in the National Action Plan on Antimicrobial Resistance (NAP-AMR) 2.0 document we opened, or in the National Treatment Guidelines for Antimicrobial Use in Infectious Disease Syndromes (Version 2.0, November 2025), a start date or a new duty that applies only because the week has begun. Existing Indian rules on prescription-only antibiotics, including Schedule H and Schedule H1 of the Drugs Rules, 1945, and CDSCO's 21 September 2026 circular, continue to apply in the same way. Our reading: treat the week as a reminder to check your records, not as a new gazette. This is a general guide, not legal advice. Recheck the current official notice before you change clinic policy.
Do I have to keep a Schedule H1 register in my clinic for antibiotics?
Not in the Drugs Rules text we use for this page, or in CDSCO's 21 September 2026 circular. That circular says most antibiotic drugs are included in Schedule H1 of the Drugs Rules, 1945. The H1 supply register is a retailer record. Rule 65(3)(1)(h), in the CDSCO compilation cited in our Schedule H1 guide, says the supply of a Schedule H1 drug shall be recorded in a separate register at the time of the supply, with the name and address of the prescriber, the name of the patient, the name of the drug and the quantity supplied, and kept for three years. That is the chemist's register, not a new pad you keep in the consulting room. What you can do is write a complete prescription the retailer can record against, including a signed, dated slip with the patient's name and address, the dose and the total amount, as Rule 65(10) already sets out for that sale condition. This is a general guide, not legal advice.
Does Medabha warn me if an antibiotic is not indicated, or if the course has no duration?
No. Medabha has no antibiotic stewardship check. It does not judge whether an antibiotic is indicated, whether two antibiotics overlap, or how long a course is. It does flag a short list of specific clashes, including clarithromycin or erythromycin with atorvastatin or simvastatin, trimethoprim or co-trimoxazole with methotrexate, and nitrofurantoin when severe kidney disease or G6PD deficiency is on the chart. Those warnings are not a judgement on whether the antibiotic should have been started. Every prescription line has a separate Duration field, printed in its own column, with starter suggestions you can replace with your own list. Signing is not blocked only because the duration is blank, or because you chose a starter such as "Till review". The decision stays with you.
Which official Indian guidance should I look at this week?
Three official documents are the ones we opened and used for this page, in addition to World Health Organization campaign pages for the week itself. CDSCO's 21 September 2026 circular restates prescription-only rules for NSAIDs and antibiotics and sets out five points for healthcare professionals; our separate guide quotes Section B in full. The National Treatment Guidelines for Antimicrobial Use in Infectious Disease Syndromes, Version 2.0, November 2025, were developed jointly by the National Centre for Disease Control and the Indian Council of Medical Research, and are intended to guide empiric antimicrobial prescribing. The National Action Plan on Antimicrobial Resistance (NAP-AMR) 2.0 (2025-2029), Version 2.0, November 2025, is the government's current plan; the Press Information Bureau says it was launched on 18 November 2025. None of these pages replaces your council, your State drug controller, or a later official notice. This page does not copy treatment regimens or doses from the guidelines. This is a general guide, not medical or legal advice.
Try Medabha in your own clinic
AI medical scribe, WhatsApp prescriptions, specialty charts and a built-in clinic website, set up in minutes.
Start 14-day free trial Prefer a walkthrough? Book a demoNo card needed.
This article is general information about clinic software and documentation workflows, not medical, legal or regulatory advice. Check current requirements with the relevant authority before making compliance decisions.